Funding from Ron Shaich helps advance promising drug development at WashU Medicine
A businessman’s strategic gift powers Alzheimer’s disease research
Funding from Ron Shaich helps advance promising drug development at WashU Medicine
Scientists know that many proteins and pathways are involved in the development and progression of neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia (FTD), and that these proteins can be detected in the plasma of people with the conditions. But it hasn’t been clear exactly which proteins are distinct to one disease […]
WashU Medicine Neurology welcomed six new faculty to the department in July 2025. We are grateful and excited to have these talented individuals join our team and look forward to seeing their contributions and achievements throughout their careers with us.
Edmond J. Safra Fellowship to fund training of movement disorder specialist in the Department of Neurology
Michael Petrany Co-administrative Chief Where I’m from Huntington, West Virginia Brief background about my education/training I moved to Cincinnati, Ohio for college at Xavier University and stayed in the city for the MD/PhD program at University of Cincinnati and Cincinnati Children’s Hospital. I completed my PhD in Doug Millay’s lab studying mechanisms of myoblast fusion […]
Arthur L. Prensky, MD, a professor emeritus of neurology at Washington University School of Medicine in St. Louis, died Monday, June 16, 2025, after a short illness. He was 94. Over his 45-year career, Prensky became a world authority in metabolic disorders, headache and neurodevelopment.
Hannah Richardson is hopeful about her future and its endless possibilities. But the 24-year-old’s plans are clouded by an unthinkable reality—there is a 50% chance she will develop Alzheimer’s disease in her 30s.
Aaron Struck, MD, associate professor of neurology, has been appointed chief of the Section of Epilepsy at WashU Medicine Neurology. His role takes effect July 1, 2025. Brian “Keith” Day, MD, PhD, has served as interim chief of the section since September 2024. During Day’s tenure, he demonstrated steady leadership and helped maintain stability and […]
A new AI-based technology that rapidly maps the brain to locate sensitive areas that control speech, vision, movement and other critical functions has received authorization from the Food and Drug Administration (FDA), enabling it to be marketed to hospitals with the aim of enhancing the precision of neurosurgeries. The technology was developed by researchers and […]
Raman Malhotra, MD, will lead the Section of Sleep Medicine starting July 1, 2025.